CAT
48
2
MAS
56
-2
EW
37
-4
CPB
44
2
OMC
33
4
NOV
33
3
MRK
48
2
PEG
60
3
PYPL
70
2
DAL
64
7
IRM
52
2
PLD
46
6
AIZ
56
6
NKE
31
-2
LOW
49
-3
MA
71
2
DHR
58
2
MDT
66
2
PHM
44
-2
FOX
44
2
CAT
48
2
MAS
56
-2
EW
37
-4
CPB
44
2
OMC
33
4
NOV
33
3
MRK
48
2
PEG
60
3
PYPL
70
2
DAL
64
7
IRM
52
2
PLD
46
6
AIZ
56
6
NKE
31
-2
LOW
49
-3
MA
71
2
DHR
58
2
MDT
66
2
PHM
44
-2
FOX
44
2
Financhill
Back

IGM Biosciences 10K Form

Sell
50

IGMS
IGM Biosciences

Last Price:
$1.32
Seasonality Move:
-10.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IGMS News And Ratings

See the #1 stock for the next 7 days that we like better than IGMS

IGMS Financial Statistics

Sales & Book Value

Annual Sales: $2.7M
Cash Flow: $-32.6M
Price / Cash Flow: 0
Annual Sales: $0.01
Price / Book: 113.68

Profitability

EPS (TTM): -3.27000
Net Income (TTM): $-198.9M
Gross Margin: --
Return on Equity: -241.68%
Return on Assets: -66.75%

IGM Biosciences Earnings Forecast

Key IGM Biosciences Financial Ratios

  • The Research & Development expenses have been 6,004.26% of Revenue.
  • The Net Earning history of IGMS is -7,308.51% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 3 years.

IGM Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IGMS
CUSIP: 449585
Website: igmbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.71
Quick Ratio: 5.39

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IGMS Technical Analysis vs Fundamental Analysis

Sell
50
IGM Biosciences (IGMS) is a Sell

Is IGM Biosciences a Buy or a Sell?

  • IGM Biosciences stock is rated a Sell
    The current IGM Biosciences [IGMS] share price is $1.32. The Score for IGMS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.